Format

Send to

Choose Destination
F1000Res. 2017 Dec 12;6:2123. doi: 10.12688/f1000research.12573.1. eCollection 2017.

Recent advances in understanding and managing T-cell lymphoma.

Author information

1
Division of Hematology-Oncology, Department of Medicine, Chung-Ang University , Seoul, Korea, South.
2
Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul, Korea, South.

Abstract

Owing to the rarity of peripheral T-cell lymphoma (PTCL) and the heterogeneity of subtypes, there are no compelling data to guide the therapeutic approaches for such patients. Over the years, there have been remarkable advances in molecular subtyping and treatment of PTCL, although there are still many areas to be explored. In this review, we summarize recent updates on the evolution of understanding and treatment for PTCL.

KEYWORDS:

Natural Killer Cells; PTCL; T-Cell lymphoma; T-lymphocytes

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

Publication type

Publication type

Supplemental Content

Full text links

Icon for F1000 Research Ltd Icon for PubMed Central
Loading ...
Support Center